2 型糖尿病肾脏病与TMAO 的相关性研究
王梦珂， 甘超， 袁玥， 邹婧怡， 王珍… - 中国临床药理学与 …, 2024 - manu41.magtech.com.cn
… kidney disease,CKD) 相关[3-4].在动物模型中发现,抑制… cardiovascular mortality in patients
with chronic kidney disease: … The fibrotic effects of TMAO on human renal fibroblasts is …
with chronic kidney disease: … The fibrotic effects of TMAO on human renal fibroblasts is …
[HTML][HTML] 肠道菌群参与糖尿病肾病的机制研究进展
徐飞， 陈瑾， 鲁育含， 李志勇 - 药学实践与服务, 2024 - 202.121.224.134
… Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed
… TMAO水平升高与CKD患者死亡风险增加相关 [45] .TMAO及其前体胆碱水平的增加与信号转导…
… TMAO水平升高与CKD患者死亡风险增加相关 [45] .TMAO及其前体胆碱水平的增加与信号转导…
[PDF][PDF] 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究
景凯， 杨慈荣， 张圳， 臧艺蓓， 刘霞 - 药学实践杂志, 2024 - yxsj.smmu.edu.cn
… of chronic heart failure in mice, which could improve cardiac function by improving myocardial
… Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-…
… Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-…
肠道菌群对动脉粥样硬化性心血管疾病影响的研究进展
赵文艳， 陈曦 - 中国全科医学, 2019 - chinagp.net
… (FMOs)的催化 下氧化为TMAO,而TMAO 为心血管疾病重要的风险… overgrowth in end-stage
kidney disease using freeze-dried … yogurt in mildly to moderately hypercholesterolemic subjects[…
kidney disease using freeze-dried … yogurt in mildly to moderately hypercholesterolemic subjects[…
非酒精性脂肪性肝病流行现状及危险因素研究进展
许耀珑， 赵佳欣， 杨立刚 - 中国全科医学, 2024 - chinagp.net
… [后将继续转化为 三甲胺- 氮氧化物(TMAO)],内毒素,内源性乙醇 等,… fatty liver disease,modest
alcohol use is associated with less … all-cause mortality in nonalcoholic fatty liver disease in the …
alcohol use is associated with less … all-cause mortality in nonalcoholic fatty liver disease in the …